Alzheimers & Memory Center | Clinical Trials | Publications | Patient Resource | Directions | Forms | Patient Portal

Alzheimers and Memory Center of NE New York

Alzheimers Memory Center of Northeastern New York

Clinical Trials

logo.gif
Empire Neurology P.C

Early Alzheimer's and pre-Alzheimer's study is now enrolling at Empire Neurology for the purpose of treating Alzheimer's disease before it becomes disability.  This can include patients who may only have mild memory problems.   Call 518-785-1000  and ask for Carol for more information
 
 
Empire Neurology continues to participate in the diagnosis and management of memory disorders, especially Alzheimer’s disease.  As reported in the New York Times front page articles on Saturday, July 17th recently, early treatment may make a real difference.  The New York Times article entitled:  Drug Trials Test Bold Plan to Slow Alzheimer’s has been a goal for many years. 

Click here for NY times article

Now at Empire Neurology, 2 drug trials are on-going designed to reduce the burden of amyloid plaque in the brain.  Amyloid plaques has been known since the time of Dr. Alzheimer himself to be a basic part of the Alzheimer’s process.  Finally, there is hope that, in addition to standard medications such as Aricept, Exelon and Namenda, there may be treatments that can slow the disease process not just treat the symptoms.

 If you wish to enroll for any of these studies or have any questions about the studies, please call our office at 518-785-1000.

New 3

           

1. A Study of CAD106 AND CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (Generation S1) ( Sponsor: Novartis Pharmaceuticals)

This study is now available for enrollment. Call Carol for more information at 518-785-1000.

Large Marble 3

Click here for more information from ClinicalTrials.gov

Click here for more information about the Generation Study:

           

2. A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients with Prodromal to Mild Alzheimer's Disease Sponsor: Genentech, Inc

This study is available for enrollment. Call Carol for more information at 518-785-1000.

Large Marble 3

Click here for more information from ClinicalTrials.gov:

           

3. A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease - (EMERGE STUDY) Sponsor: Biogen

This study is now available for enrollment. Call Carol for more information at 518-785-1000.

Large Marble 3

Click here for more information from ClinicalTrials.gov:


Empire Neurology, P.C 
 Riverhill Center, Suite 105, 1205 Troy-Schenectady Road, Latham, NY, US,  12110  Phone:  518-785-1000